Micro Cap Growth Fund
Daily price w/o sales charge as of 06/10/2026
$23.25
$0.38
YTD Returns w/o sales charge as of 06/10/2026
19.29%
Overall Morningstar RatingsSmall Growth
as of 05/31/2026
Morningstar rated the Lord Abbett Micro Cap Growth Fund class A share 3, 3 and 5 stars among 520, 497 and 399 Small Growth Funds for the overall rating and the 3, 5 and 10 year periods ended 5/31/2026, respectively.
Please click here for performance current to the most recent quarter-end and month-end.
Summary
Summary
Fund Basicsas of 05/29/2026
- Total Net Assets
- $220.27 M
- Inception Date
- 05/01/2000
- Dividend Frequency
- Annually
- Fund Gross Expense Ratio
- 1.37%
- Fund Net Expense Ratio
- 1.37%
- Number of Holdings
- 82
- Minimum Initial Investment
- $1,500+
Fund Expense Ratio :
Gross 1.37%
Net 1.37%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 05/01/2000 |
|---|
| w/o sales charge | 26.58% | 54.48% | 20.39% | 5.20% | 18.16% | 11.12% |
| Lipper Category Avg. Small-Cap Growth Funds | 14.68% | 32.30% | 16.96% | 4.08% | 11.71% | - |
| Russell Microcap® Growth Index | 18.89% | 57.45% | 23.66% | 3.79% | 10.16% | - |
| w/ sales charge | 19.29% | 45.63% | 18.04% | 3.96% | 17.47% | 10.87% |
Fund Expense Ratio :
Gross 1.37%
Net 1.37%
Fund Expense Ratio :
Gross 1.37%
Net 1.37%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 05/01/2000 |
|---|
| w/o sales charge | 0.21% | 35.16% | 12.22% | -0.57% | 16.05% | 10.20% |
| Lipper Category Avg. Small-Cap Growth Funds | -2.19% | 18.82% | 10.03% | 1.17% | 10.44% | - |
| Russell Microcap® Growth Index | -4.25% | 41.85% | 15.49% | -1.21% | 8.34% | - |
| w/ sales charge | -5.56% | 27.40% | 10.03% | -1.75% | 15.37% | 9.94% |
Fund Expense Ratio :
Gross 1.37%
Net 1.37%
Returns with sales charges reflect a maximum sales charge of 5.75%.
Past performance is not a reliable indicator or guarantee of future results. Current performance may be higher or lower than the performance data quoted. Returns shown include the reinvestment of all distributions. Returns shown at net asset value do not reflect the current maximum sales charge, had the sales charge been included, returns would have been lower. The investment return and principal value of an investment will fluctuate so that shares, on any given day or when redeemed, may be worth more or less than the original cost.
TEN LARGEST HOLDINGS as of 04/30/2026View Portfolio
| Holding | Assets |
|---|---|
| Cogent Biosciences Inc | 3.3% |
| Legence Corp | 3.2% |
| Terawulf Inc | 3.1% |
| Aehr Test Systems | 3.1% |
| Celcuity Inc | 2.9% |
| Applied Digital Corp | 2.6% |
| Cardinal Infrastructure Group Inc | 2.5% |
| Sterling Infrastructure Inc | 2.3% |
| Adaptive Biotechnologies Corp | 2.2% |
| Bel Fuse Inc | 2.2% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
Sector Allocationas of 05/29/2026View Portfolio
| Sector | Weighting |
|---|
| Sector | Weighting |
|---|---|
| Communication Services | |
| Real Estate | |
| Utilities | |
| Consumer Discretionary | |
| Consumer Staples | |
| Energy | |
| Financials | |
| Health Care | |
| Industrials | |
| Information Technology | |
| Materials |
INVESTMENT TEAM
Your Representative
To contact your representative, enter your zip code and select your channel below.
Performance
Performance
Fund Expense Ratio :
Gross 1.37%
Net 1.37%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 05/01/2000 |
|---|
| w/o sales charge | 26.58% | 54.48% | 20.39% | 5.20% | 18.16% | 11.12% |
| Lipper Category Avg. Small-Cap Growth Funds | 14.68% | 32.30% | 16.96% | 4.08% | 11.71% | - |
| Russell Microcap® Growth Index | 18.89% | 57.45% | 23.66% | 3.79% | 10.16% | - |
| w/ sales charge | 19.29% | 45.63% | 18.04% | 3.96% | 17.47% | 10.87% |
Fund Expense Ratio :
Gross 1.37%
Net 1.37%
Fund Expense Ratio :
Gross 1.37%
Net 1.37%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 05/01/2000 |
|---|
| w/o sales charge | 0.21% | 35.16% | 12.22% | -0.57% | 16.05% | 10.20% |
| Lipper Category Avg. Small-Cap Growth Funds | -2.19% | 18.82% | 10.03% | 1.17% | 10.44% | - |
| Russell Microcap® Growth Index | -4.25% | 41.85% | 15.49% | -1.21% | 8.34% | - |
| w/ sales charge | -5.56% | 27.40% | 10.03% | -1.75% | 15.37% | 9.94% |
Fund Expense Ratio :
Gross 1.37%
Net 1.37%
Returns with sales charges reflect a maximum sales charge of 5.75%.
Past performance is not a reliable indicator or guarantee of future results. Current performance may be higher or lower than the performance data quoted. Returns shown include the reinvestment of all distributions. Returns shown at net asset value do not reflect the current maximum sales charge, had the sales charge been included, returns would have been lower. The investment return and principal value of an investment will fluctuate so that shares, on any given day or when redeemed, may be worth more or less than the original cost.
| Year | Fund Returns | Russell Microcap® Growth Index |
|---|
| 2025 | 10.74% | 21.84% |
| 2024 | 26.89% | 21.91% |
| 2023 | 5.88% | 9.11% |
| 2022 | -29.27% | -29.76% |
| 2021 | 3.46% | 0.88% |
| 2020 | 79.42% | 40.13% |
| 2019 | 34.57% | 23.33% |
| 2018 | 2.74% | -14.18% |
| 2017 | 38.43% | 16.65% |
| 2016 | 2.07% | 6.86% |
| 2015 | -6.38% | - |
| 2014 | 10.83% | - |
| 2013 | 78.53% | - |
| 2012 | 2.35% | - |
| 2011 | -5.87% | - |
| 2010 | 33.77% | - |
| 2009 | 52.61% | - |
| 2008 | -46.45% | - |
| 2007 | 22.76% | - |
| 2006 | 25.37% | - |
| Year | Q1 | Q2 | Q3 | Q4 |
|---|
| 2026 | 0.21% | - | - | - |
| 2025 | -17.90% | 15.85% | 13.92% | 2.20% |
| 2024 | 7.64% | 0.07% | 6.89% | 10.21% |
| 2023 | 5.50% | 4.20% | -13.40% | 11.23% |
| 2022 | -17.22% | -22.57% | 8.17% | 2.02% |
| 2021 | 12.29% | -0.15% | -9.42% | 1.87% |
| 2020 | -24.28% | 47.61% | 17.48% | 36.65% |
| 2019 | 22.67% | 7.47% | -13.91% | 18.57% |
| 2018 | 5.24% | 15.77% | 10.08% | -23.39% |
| 2017 | 9.00% | 8.12% | 13.61% | 3.39% |
| 2016 | -13.70% | 6.01% | 14.49% | -2.55% |
| 2015 | 7.33% | 4.15% | -16.30% | 0.06% |
| 2014 | 7.92% | -6.53% | -6.55% | 17.58% |
| 2013 | 21.83% | 15.00% | 17.29% | 8.65% |
| 2012 | 17.67% | -9.76% | 1.32% | -4.87% |
| 2011 | 4.82% | 0.11% | -21.90% | 14.86% |
| 2010 | 6.60% | -8.74% | 15.08% | 19.49% |
| 2009 | -0.95% | 31.46% | 13.47% | 3.29% |
| 2008 | -23.22% | 4.46% | -5.93% | -29.02% |
| 2007 | 5.64% | 9.81% | 4.01% | 1.76% |
| 2006 | 17.15% | -9.83% | 1.22% | 17.25% |
| 2005 | -9.50% | 5.88% | 6.91% | 0.10% |
| 2004 | 12.33% | 1.65% | -11.11% | 24.03% |
| 2003 | -3.55% | 27.29% | 11.68% | 8.93% |
| 2002 | -0.18% | -12.74% | -21.79% | 1.33% |
| 2001 | 2.34% | 12.03% | -21.11% | 29.32% |
Performance is shown for each quarter and each calendar year. Past performance is no guarantee of future results.
Growth of $10,000 as of 05/31/2026
The chart begins on the Fund's inception date of 05/01/2000.
Based on a hypothetical Class A share investment of $10,000 on 05/01/2000 without sales charge and includes the reinvestment of all distributions.
NAV Historical Prices
| Date | Net Asset Value |
|---|
Portfolio
Portfolio
| Holding | Sector | Assets |
|---|
| Cogent Biosciences Inc | Health Care | 3.3% |
| Legence Corp | Industrials | 3.2% |
| Terawulf Inc | Information Technology | 3.1% |
| Aehr Test Systems | Information Technology | 3.1% |
| Celcuity Inc | Health Care | 2.9% |
| Applied Digital Corp | Information Technology | 2.6% |
| Cardinal Infrastructure Group Inc | Industrials | 2.5% |
| Sterling Infrastructure Inc | Industrials | 2.3% |
| Adaptive Biotechnologies Corp | Health Care | 2.2% |
| Bel Fuse Inc | Information Technology | 2.2% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
| Holding | Sector | Assets |
|---|
| Cogent Biosciences Inc | Health Care | 3.3% |
| Legence Corp | Industrials | 3.2% |
| Terawulf Inc | Information Technology | 3.1% |
| Aehr Test Systems | Information Technology | 3.1% |
| Celcuity Inc | Health Care | 2.9% |
| Applied Digital Corp | Information Technology | 2.6% |
| Cardinal Infrastructure Group Inc | Industrials | 2.5% |
| Sterling Infrastructure Inc | Industrials | 2.3% |
| Adaptive Biotechnologies Corp | Health Care | 2.2% |
| Bel Fuse Inc | Information Technology | 2.2% |
| Tarsus Pharmaceuticals Inc | Health Care | 2.1% |
| Mirum Pharmaceuticals Inc | Health Care | 2.1% |
| CECO Environmental Corp | Industrials | 2.0% |
| Vita Coco Co Inc/The | Consumer Staples | 1.9% |
| Applied Optoelectronics Inc | Information Technology | 1.8% |
| Navan Inc | Consumer Discretionary | 1.8% |
| Nektar Therapeutics | Health Care | 1.8% |
| Sphere Entertainment Co | Communication Services | 1.7% |
| Lincoln Educational Services Corp | Consumer Discretionary | 1.7% |
| Universal Technical Institute Inc | Consumer Discretionary | 1.7% |
| Dianthus Therapeutics Inc | Health Care | 1.6% |
| Navitas Semiconductor Corp | Information Technology | 1.6% |
| Mercury Systems Inc | Industrials | 1.6% |
| IMAX Corp | Communication Services | 1.5% |
| Lindblad Expeditions Holdings Inc | Consumer Discretionary | 1.4% |
| PTC Therapeutics Inc | Health Care | 1.4% |
| OSI Systems Inc | Information Technology | 1.3% |
| MYR Group Inc | Industrials | 1.3% |
| VSE Corp | Industrials | 1.3% |
| Piper Sandler Cos | Financials | 1.3% |
| Argan Inc | Industrials | 1.3% |
| AAR Corp | Industrials | 1.3% |
| Praxis Precision Medicines Inc | Health Care | 1.3% |
| Aevex Corp | Industrials | 1.3% |
| Miami International Holdings Inc | Financials | 1.3% |
| BlackSky Technology Inc | Industrials | 1.3% |
| York Space Systems Inc | Industrials | 1.3% |
| Fastly Inc | Information Technology | 1.3% |
| StoneX Group Inc | Financials | 1.2% |
| Standex International Corp | Industrials | 1.1% |
| Mineralys Therapeutics Inc | Health Care | 1.1% |
| Chefs' Warehouse Inc/The | Consumer Staples | 1.1% |
| Gilat Satellite Networks Ltd | Information Technology | 1.0% |
| 10X Genomics Inc | Health Care | 1.0% |
| nLight Inc | Information Technology | 1.0% |
| Neptune Insurance Holdings Inc | Financials | 0.9% |
| Enliven Therapeutics Inc | Health Care | 0.9% |
| Xometry Inc | Industrials | 0.9% |
| Oruka Therapeutics Inc | Health Care | 0.9% |
| Pattern Group Inc | Consumer Discretionary | 0.9% |
| Willdan Group Inc | Industrials | 0.8% |
| WisdomTree Inc | Financials | 0.7% |
| Rhythm Pharmaceuticals Inc | Health Care | 0.7% |
| Dave Inc | Financials | 0.7% |
| Transcat Inc | Industrials | 0.7% |
| American Public Education Inc | Consumer Discretionary | 0.7% |
| Paymentus Holdings Inc | Financials | 0.7% |
| Mama's Creations Inc | Consumer Staples | 0.6% |
| Primoris Services Corp | Industrials | 0.6% |
| Artivion Inc | Health Care | 0.6% |
| HeartFlow Inc | Health Care | 0.6% |
| Warby Parker Inc | Consumer Discretionary | 0.6% |
| Marex Group PLC | Financials | 0.6% |
| Ouster Inc | Information Technology | 0.6% |
| Newamsterdam Pharma Co NV | Health Care | 0.5% |
| TAT Technologies Ltd | Industrials | 0.5% |
| Hinge Health Inc | Health Care | 0.5% |
| Calix Inc | Information Technology | 0.5% |
| Ondas Inc | Information Technology | 0.5% |
| Cipher Digital Inc | Information Technology | 0.5% |
| Billiontoone Inc | Health Care | 0.5% |
| CG oncology Inc | Health Care | 0.5% |
| Twist Bioscience Corp | Health Care | 0.5% |
| Ceribell Inc | Health Care | 0.4% |
| Forte Biosciences Inc | Health Care | 0.4% |
| Relay Therapeutics Inc | Health Care | 0.4% |
| Neogen Corp | Health Care | 0.4% |
| GeneDx Holdings Corp | Health Care | 0.4% |
| Alamar Biosciences Inc | Health Care | 0.4% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
Sector Allocationas of 05/29/2026
| Sector | Weighting | Fund Change from Previous Quarter |
|---|
| Sector | Weighting | Fund Change from Previous Quarter |
|---|---|---|
| Communication Services |
0.1%
|
|
| Real Estate | 0.0% | |
| Utilities | 0.0% | |
| Consumer Discretionary |
0.7%
|
|
| Consumer Staples |
0.1%
|
|
| Energy |
0.4%
|
|
| Financials |
 1.5%
|
|
| Health Care |
8.5%
|
|
| Industrials |
1.6%
|
|
| Information Technology |
5.4%
|
|
| Materials | 0.0% |
Portfolio Details as of 05/29/2026
- Total Net Assets
- $220.27 M
- Number of Holdings
- 82
- Weighted Average Market Cap.
- 4.9 B
- P/B Ratio
- 7.5x
- P/E Ratio
- 39.1x
To view definitions for the above Portfolio Details, Click here.
P/B Ratio - A ratio that helps determine whether a stock is undervalued or overvalued. It is calculated by dividing a stock's price per share by its book value per share. The result is based upon a weighted average of the securities held in the fund.
P/E Ratio - Is the weighted average of each holding's P/E ratio (price of a stock divided by its earnings per share). The result is based upon a weighted average of the securities held in the fund.
Weighted Average Market Cap - The average market capitalization of all companies held in the portfolio with each company weighted according to its percent held in the portfolio. The result is based upon a weighted average of the securities held in the fund.
Dividends & Cap Gains
Dividends & Cap Gains
Dividend Payments
- YTD Dividends Paidas of 06/10/2026
- $0
- Dividend Frequency
- Annually
| Record Date | Ex-Dividend Date | Reinvest & Payable Date | Dividend | Reinvest Price |
|---|---|---|---|---|
| 11/20/2001 | 11/21/2001 | 11/21/2001 | $0.00740 | $10.09 |
Upcoming Dividend Payment Dates
This section lists all anticipated Income and Capital Gain distribution dates and any actual distributions are subject to adequacy of earnings and must be approved by the Board of Directors/Trustees. Please note that dates are subject to change.
| Record Date | Ex-Dividend Date | Reinvest & Payable Date |
|---|---|---|
| 11/23/2026 | 11/24/2026 | 11/24/2026 |
Capital Gains Distributions
| Record Date | Reinvest & Payable Date | Long-term | Short-term * | Total | Reinvest Price |
|---|---|---|---|---|---|
| 11/23/2020 | 11/24/2020 | $2.8043 | $2.2741 | $5.0784 | $15.43 |
Taxed as ordinary income
Lord Abbett does not provide tax advice. It is strongly recommended that you discuss the impact of dividends and distributions with your tax advisor.
Fees & Expenses
Fees & Expenses
Sales Charge Schedule as of 06/10/2026
| Sales Charge | Dealer's Concession | Prices at Breakpoint | |
|---|---|---|---|
| Less than $50,000 | 5.75% | 5.00% | $24.67 |
| $50,000 to $99,999 | 4.75% | 4.00% | $24.41 |
| $100,000 to $249,999 | 3.95% | 3.25% | $24.21 |
| $250,000 to $499,999 | 2.75% | 2.25% | $23.91 |
| $500,000 to $999,999 | 1.95% | 1.75% | $23.71 |
| $1,000,000 to $5,000,000 | 0.00% | 1.00% | $23.25 |
The 12b-1 trail commission is 0.15% (accrues immediately) for all fixed-income and municipal income funds.
Class A shares purchased without a sales charge (commissionable NAV) will be subject to a CDSC of 1% if they are redeemed before the first day of the month in which the one-year anniversary of the purchase falls.
Expense Ratioas of 04/30/2026
| Fund Gross Expense Ratio | 1.37% |
| Fund Net Expense Ratio | 1.37% |
Fund Documents
Fund Documents
|
0Documents selected
|
||||
|---|---|---|---|---|
|
Portfolio Holdings 1Q
Publish Date:11/03/2015
|
||||
|
Portfolio Holdings 3Q
Publish Date:11/03/2015
|
||||
|
Summary Prospectus
Publish Date:11/03/2015
|
||||
|
Statutory Prospectus
Publish Date:11/03/2015
|
||||
|
SAI
Publish Date:11/03/2015
|
||||
|
Annual Financial Statements and Other Information *
Publish Date:11/03/2015
|
||||
|
2025 Annual Tailored Shareholder Report
Publish Date:11/03/2015
|
||||
|
2025 Semi-Annual Tailored Shareholder Report
Publish Date:11/03/2015
|
||||
|
Semi-Annual Financial Statements and Other Information *
Publish Date:11/03/2015
|
||||
|
Fact Sheet
Publish Date:11/03/2015
|